For both men and women, slimming down a double chin is one of the top cosmetic goals. That’s why Natural Aesthetics is excited to offer KYBELLA — the “double chin injection”. KYBELLA is a breakthrough injectable treatment cleared by the FDA to reduce the fat that creates a double chin.
Learn more about KYBELLA and whether you can benefit from the treatment by requesting a consultation.
Deoxycholic acid is a molecule that occurs naturally in the body to help break down and absorb dietary fat. It is also the active ingredient in KYBELLA, and it is clinically proven to reduce submental fat — the stubborn fat just below the chin. There are several reasons men and women develop double chins. They can be inherited or caused by aging or weight gain. KYBELLA injections create the more refined chin and streamlined neck that most people consider attractive and youthful-looking.
Once KYBELLA is injected, it destroys fat cells in the treatment area. Your body gradually absorbs those cells and naturally flushes them out through the metabolic process.
Before KYBELLA, surgical liposuction was the only way to correct the fat that causes a double chin. Some patients who have more fat may still be better candidates for liposuction, but for those with moderate double chin fat, KYBELLA represents an excellent nonsurgical alternative. Our team will help you decide which is the best treatment for your goals.
Please reach us at Glenna@naturalaestheticsspa.com if you cannot find an answer to your question.
KYBELLA® is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.” It is not known if KYBELLA® is safe and effective for the treatment of fat outside of the submental area or in children under 18 years of age.
Only you and your doctor can decide if KYBELLA® is right for you. If you’re bothered by fullness under your chin and wish to avoid surgery, ask your doctor about KYBELLA®.
Your specialist will create a tailored treatment plan based on your chin profile. At each treatment, you will be given multiple small injections under your chin. You may receive up to 6 treatment sessions, spaced at least 1 month apart. Many patients experience visible results in 2 to 4 KYBELLA® treatments. 59% of patients received 6 treatments in clinical studies.
The active ingredient in KYBELLA® is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, KYBELLA® destroys fat cells, and once destroyed, these cells can no longer store or accumulate fat. This results in a noticeable reduction in fullness under the chin, revealing an improved chin profile.
When injected into fat under the chin, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After reaching your desired aesthetic, further treatment is not expected.
KYBELLA® can cause serious side effects, including injection site problems such as bruising, hair loss, open sores (ulcers), and damage and tissue cell-death (necrosis) around the injection site or trouble swallowing and nerve injury in the jaw that can temporarily cause an uneven smile or facial muscle weakness. In clinical studies, nerve injury in the jaw resolved on its own in a median of 44 days (range of 1 to 298 days), and trouble swallowing resolved on its own in a median of 3 days (range of 1 to 81 days).
The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. These are not all of the possible side effects of KYBELLA®. Call your healthcare provider if you develop open sores or drainage from the treatment area or for medical advice about side effects.
Copyright © 2024 Natural Aesthetics - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.